IN A NUTSHELL
Changing Private Practice Medicine
This approach isn’t just better for doctors—it’s better for business and for patient outcomes. We invite accredited investors to join us in reshaping the future of medicine through sustainable, physician-aligned growth and real value creation.
COMMON QUESTIONS
Q. Do I have to be an accredited investor?
A. Yes. At this time, investment opportunities are available exclusively to accredited investors. If you're unsure whether you qualify, we’re happy to walk you through the criteria.
Q. How are the investments structured?
A. We use Special Purpose Vehicles (SPVs) to invest in individual clinics. You invest capital into one of these SPVs, which then holds equity in the clinic or group of clinics. This structure offers flexibility, transparency, and targeted exposure to healthcare assets.
Q. Is there a minimum investment?
A. Yes. The current minimum investment is $50,000 USD.
Q: How are returns generated for investors?
A: Returns are generated through a combination of operational cash flow and long-term equity growth. Clinics in the AreMed network typically experience increased profitability due to centralized management, better reimbursement strategies, and optimized staffing and overhead. Investors may receive distributions from ongoing clinic performance, but the primary value lies in the roll-up exit strategy—where consolidated clinics are sold at a higher multiple, creating a strong equity return.
Q. Can a non-physician have ownership in a medical clinic?
A. Yes—but ownership must comply with Corporate Practice of Medicine (CPOM) laws, which vary by state. In most cases, the physician retains equity and always retains full control over clinical decision-making. We structure each investment to ensure full legal and regulatory compliance.
Q. What is the exit strategy?
A. AreMed’s long-term strategy involves rolling up affiliated clinics into a single platform exit. By scaling both revenue and EBITDA across multiple practices, we expect to command significantly higher valuation multiples—resulting in stronger returns for all equity holders.
Q. What do doctors think of this concept?
A. Independent physicians are increasingly aware that the old solo model is no longer sustainable. Many are wary of traditional corporate consolidation due to its negative impact on both their income and autonomy. AreMed’s approach is different: it preserves clinical independence, recognizes the central role of physicians, and helps them thrive in today’s challenging environment. Many doctors express relief—and even excitement—when presented with a model that truly respects their value.
Answer: Our proprietary Profitability 5™ framework pinpoints key areas where your clinic may be underperforming—such as billing, staffing, and marketing. We implement targeted solutions, including optional Bolt-On Clinics™, to boost revenue, improve margins, and strengthen overall clinic performance. Our goal is simple: handle the business side so you can focus on what you do best—practicing medicine.
Answer: Bolt-On Clinics™ are turnkey service lines—such as wellness optimization, regenerative care, wound care, and post-stroke recovery—that seamlessly integrate into your existing practice. They leverage your current space, staff, and patient base to generate new revenue with minimal disruption. We offer several proven options and will work with you to determine the best fit for accelerating your clinic’s growth.
Answer: Unlike traditional private equity groups, we don’t buy out physicians or compromise clinical autonomy. Our model protects your medical decision-making while strengthening the business side—so you stay in control and benefit from long-term equity growth. Whether you're years from retirement or exploring options now, our flexible model adapts to your goals and offers a superior, more physician-friendly exit strategy than typical consolidators.
Answer: No. We offer both MSO-only partnerships and equity + MSO options, allowing you to choose the path that best aligns with your goals—whether that means offloading business operations now or planning for a stronger, future exit. Our approach is flexible by design, but one thing remains constant: you stay in control and at choice—a level of flexibility rarely offered in traditional models.
Answer: We target a 20–35% IRR through our Clinic SPV rollup strategy, driven by real EBITDA growth and targeted exit multiples ranging from 10x to 16x. Investments are structured as convertible debt with built-in equity kickers, offering strong long-term upside. The result is a return profile competitive with traditional private equity—but backed by a model that promotes stronger physician alignment and collaboration, both now and into the future.
Email: [email protected]
Phone: 303-949-7886
Address: PO Box 12102, Kansas City, MO 64153
Copyright 2025. AreMed™ Management Services, LLC. All rights reserved.